Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines.
This week the U.S. Food and Drug Administration expanded the use of the drug ibrutinib to treat patients who have chronic lymphocytic leukemia (CLL) – with UR Medicine’s James P. Wilmot Cancer Center participating in research that supported accelerated approval of the drug.
Obese women expecting twins may be able to gain less weight than recommended without harming their babies, according to a new study presented at The Pregnancy Meeting of the Society for Maternal-Fetal Medicine.
Current efforts to grade the quality of care hospitals provide stroke patients have a big flaw according to a new study in the journal Stroke. Measures of mortality – whether or not a stroke patient dies shortly after being admitted to a hospital – do not take into account whether these deaths occurred because of poor care or because physicians were carrying out the wishes of the patient and their family to withhold care.
The drug tamoxifen appears to kill a fungus associated with a deadly brain infection that afflicts HIV/AIDS patients, according to a new University of Rochester study in mBio, the journal of the American Society for Microbiology.
A new UR contest is encouraging students and trainees, as well as the whole research community, to think about how to turn advances in basic and applied sciences more quickly – and safely – into new ways to improve health.
The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.
April 2014 (4)
March 2014 (8)
February 2014 (11)
January 2014 (6)
December 2013 (10)
November 2013 (5)
October 2013 (8)
September 2013 (7)
August 2013 (12)
July 2013 (12)
June 2013 (14)
May 2013 (2)